Revisions Log

A log of revisions to articles and news stories.

Nov 30 2023 - Title changed as misleading "Alcohol consumption may have counteractive effects on heart disease risk" to "Study suggests a complex metabolic basis between alcohol consumption and CVD". The original headline "Alcohol consumption may have counteractive effects on heart disease risk, study finds" does not accurately reflect the findings of the study. The research primarily identified 60 metabolites associated with long-term alcohol consumption and their complex relationship with cardiovascular disease (CVD). It didn't conclude that alcohol consumption has counteractive effects on heart disease risk but rather showed a complex metabolic basis between alcohol consumption and CVD.

Study suggests a complex metabolic basis between alcohol consumption and CVD

Nov 16 2023 - To address the concerns raised by the research team, the following changes should be made to the news article "Study highlights risks of high-dose naloxone in opioid overdose response": Correction of Administration Route: Replace all instances where 'intravenous naloxone' is mentioned with 'intranasal naloxone'. This error appears in the first paragraph, twice in the results section, and in the conclusion. Clarification of Naloxone Dosage: In the introduction and background, the term 'low-dose naloxone' should be corrected to 'standard dose naloxone'. The study compares standard dose naloxone with high-dose naloxone, and the current wording inaccurately suggests a focus on low-dose naloxone. Accurate Representation of the Research Team: Amend the 'About the study' section to reflect that the two members from Tennessee Harm Reduction were key members of the research team, not merely consultants. Correcting Efficacy Information: Remove or correct the statement claiming intranasal naloxone is less effective, as this does not align with the findings of the study. These revisions will ensure the article aligns accurately with the original research. The research team has offered their assistance for any further clarification required.

Study highlights risks of high-dose naloxone in opioid overdose response

Nov 2 2023 - Extra journal references added to reflect the new content added

Cancer Research

Nov 2 2023 - Updates added to Molecular basis of cancer and Cancer prevention and early detection

Cancer Research

Oct 25 2023 - New sections added: Epigenetics in Type 1 Diabetes, Latest Advances in Type 1 Diabetes Research, and Testing New Immunotherapies to Prevent Type 1 Diabetes

Type 1 Diabetes Research

Oct 24 2023 - Improvement to general flow of article minor punctuation fixes and the addition of a new image.

What is Type 2 Diabetes?

Oct 24 2023 - Improvement to general tone of article and punctuation. Main image replaced with larger image.

What are Allergies?

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback